Skip to main content
Hanshang Group Co.,Ltd. logo

Hanshang Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600774 ISIN · CNE000000NC5 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,570 across all filing types
Latest filing 2023-08-22 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600774

About Hanshang Group Co.,Ltd.

https://www.whhsg.com/

Hanshang Group Co.,Ltd. is a diversified enterprise focused on commercial operations, exhibition services, and healthcare. The company manages a portfolio of large-scale department stores, shopping malls, and specialized retail outlets. Its exhibition segment provides comprehensive venue management and event organization services for international and domestic trade fairs. Hanshang Group has significantly expanded its presence in the healthcare sector through the development and distribution of pharmaceuticals, medical devices, and health-related products. By integrating traditional commercial assets with modern biomedical research and health management services, the group targets a broad consumer base and professional medical markets, emphasizing a strategic transition toward a comprehensive health-oriented business model.

Recent filings

Filing Released Lang Actions
汉商集团关于本次交易采取的保密措施及保密制度的说明
Regulatory Filings
2023-08-22 Chinese
汉商集团关于本次交易符合《上市公司监管指引第9号-上市公司筹划和实施重大资产重组的监管要求》第四条规定的说明
Regulatory Filings
2023-08-22 Chinese
汉商集团独立董事关于公司发行股份及支付现金购买资产并募集配套资金暨关联交易的事前认可意见
Capital/Financing Update Classification · 95% confidence The document is an independent directors' pre-approval opinion regarding a company's issuance of shares and cash to purchase assets and raise supporting funds, involving a major asset restructuring transaction. It references compliance with various laws and regulations related to major asset restructuring and governance, and it is a formal opinion submitted for board meeting consideration. The document is not a full report but rather a formal approval or opinion statement related to a capital/financing transaction and major asset restructuring. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short (1445 characters), and it contains substantive content about the transaction, not just an announcement or certification, so it is not RPA or RNS.
2023-08-22 Chinese
汉商集团关于本次交易履行法定程序的完备性、合规性及提交法律文件有效性的说明
Regulatory Filings
2023-08-22 Chinese
汉商集团关于暂不召开股东大会审议本次发行股份及支付现金购买资产并募集配套资金事项的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 汉商集团股份有限公司 regarding the decision to temporarily not hold a shareholders' meeting to review a major asset restructuring involving issuance of shares and cash payment for asset acquisition and fundraising. It references regulatory requirements and pending audit and evaluation work. The document is short (879 characters) and serves as a formal announcement about postponing the shareholder meeting and related transaction approvals. It does not contain financial statements or detailed financial data, nor is it a full report. It is an announcement about a capital/financing transaction and related procedural update. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-08-22 Chinese
汉商集团关于本次交易符合《上市公司重大资产重组管理办法》第十一条和第四十三条规定的说明
Regulatory Filings
2023-08-22 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.